A visual chart showing stage and indication per asset, consistent structured data across every entry, and language checked for precision against what is publicly verifiable — investors and analysts check pipeline claims against public trial registries, so vague or inflated status descriptions get caught quickly.
A clear chart showing every asset’s stage, indication and current status, scannable in seconds, since most readers check the chart before reading any surrounding text.
Every asset presented with the same fields — stage, mechanism, indication, status — structured consistently rather than each entry formatted individually, so the page stays coherent as the pipeline grows.
Status language checked specifically for accuracy against what is publicly verifiable, since investors and scientific partners routinely check pipeline claims against registries like ClinicalTrials.gov. See pipeline page for how we build and verify that precision.
Your clinical and regulatory team makes that determination, not the website team — we structure and present whatever stage information you confirm, without adjusting or interpreting it ourselves. Getting this wrong, even unintentionally, creates a credibility and compliance problem, so the page should always be reviewed and signed off by the team that owns the underlying data.
Update it whenever an asset’s actual status changes rather than on a fixed schedule, since a stale pipeline page misrepresents where the company stands. Build the page with an update process your own team can use directly, without needing developer support each time, so a change in trial phase or indication gets reflected promptly.
Yes — a pipeline page is a persistent, always-current site reference that anyone can check at any time, while an investor deck is a point-in-time presentation built for a specific audience and meeting. Both need to say the same thing, but they serve different purposes. See investor deck design for the presentation-format equivalent.
Generally not on the live pipeline itself, but many companies keep a short, factual note or separate archive rather than erasing the history entirely, particularly if the asset was previously public. Decide this with your regulatory and communications team, since silently removing an asset can raise more questions than a brief, honest explanation would.
Tell us your pipeline and we will tell you how we would structure and verify it.